Making an Impact: Prog Ret Eye Res CXL Review
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
Dr. Emilio Torres-Netto of the ELZA Institute was awarded the AAO Achievement Award at the 2024 Annual Meeting in Chicago, recognizing his contributions to ophthalmology through education, research, and service.
In a recently published case report in American Journal of Ophthalmology Case Reports, our team, in collaboration with Brazilian colleagues, describes an unusual case of a “CTK-like syndrome” following sequential intracorneal ring segment (ICRS) implantation and corneal cross-linking (CXL) in a young patient with progressive keratoconus.
Dr. Dr. Torres-Netto explained to OSN how ELZA-STARK addresses astigmatism in patients with a history of radial keratotomy (RK).
Innovations in Corneal Cross-Linking (CXL): A Look at 25 Years of Progress
Monday, September 9 is the last day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
Sunday, September 8th is the third day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
Saturday, September 7 is the second day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
Friday, September 6 was the first day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons. Here’s a collection of images from that day.
The STEP system utilizes two parameters: the minimum overall stromal thickness (ST) and the standard deviation of epithelial thickness (EP). This approach provides a more detailed understanding of keratoconus progression, offering insights that may assist in clinical decisions, especially concerning corneal cross-linking (CXL) protocols.
Mantenha-se informado & receba o boletim informativo
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.